[144] GLOBUS MEDICAL INC SEC Filing

Rhea-AI Filing Summary

Globus Medical (GMED): A stockholder filed a Form 144 notice to sell up to 25,000 shares of GMED common stock, reflecting an aggregate market value of $2,106,000. The planned broker is Raymond James & Associates, with sales listed for the NYSE and an approximate sale date of 11/11/2025.

The shares were acquired the same day via a cashless stock option exercise from the issuer for 25,000 shares, noted as a “Cashless Exercise.” The filing also lists 133,839,166 shares outstanding.

Insights

Capital markets counsel

Routine Form 144 for 25,000 shares from option exercise.

This is a notice of a proposed sale under Rule 144 for 25,000 GMED common shares with an aggregate market value of $2,106,000. The shares were obtained via a cashless stock option exercise on 11/11/2025, which commonly results in immediate or near-term sale planning to cover tax or monetize options.

The plan identifies Raymond James & Associates as broker and the NYSE as the exchange. Form 144 is informational and does not guarantee execution; actual sales can vary by market conditions and seller decisions. The table lists 133,839,166 shares outstanding, which is a baseline figure for context.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Raymond James & Associates 880 Carillon Parkway St. Petersburg FL 33716	25000	2106000.00	133839166	11/11/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/11/2025	Cashless Stock Option Exercise	Issuer			25000	11/11/2025	Cashless Exercise

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)